'Golden spice' shown to support fat loss and promote notable waistline reductions

Individuals with type 2 diabetes experienced moderate weight reduction when taking turmeric supplements, according to a meta-analysis.

Research published in Nutrition & Diabetes revealed participants achieved an average weight decrease of 1.9 kilograms, equivalent to approximately 4.2 pounds, compared with placebo groups.

The analysis encompassed 14 clinical trials specifically examining turmeric's impact on body weight among diabetic patients.

Notably, individuals with a body mass index below 30 experienced enhanced results, achieving weight reductions of 2.2 kilograms or roughly 4.8 pounds.

These findings suggest the golden spice commonly found in kitchens could offer supplementary benefits for diabetes management.

The systematic review analysed 20 carefully selected studies, with daily dosages varying from 80 milligrams to 2,100 milligrams. Treatment durations spanned between eight and 36 weeks across the trials.

Researchers categorised interventions into three distinct types: standard curcumin, enhanced-absorption curcumin formulations, and turmeric preparations.

The analysis revealed that participants consuming more than 1,500 milligrams daily experienced superior outcomes.

Extended supplementation periods exceeding 22 weeks produced more substantial results.

Individuals with prediabetes demonstrated particularly encouraging responses, recording average weight reductions of 2.5 kilograms, approximately 5.5 pounds, alongside waist circumference decreases of nearly three centimetres.

The findings arrive as diabetes affects over 536 million individuals worldwide, according to 2021 data, with projections indicating continued growth.

The condition represents a multifaceted metabolic disorder characterised by the body's inability to regulate blood glucose effectively.

The condition frequently correlates with abdominal weight gain and can precipitate severe complications affecting vision, nervous system function, kidney health and cardiovascular wellbeing.

Conventional pharmaceutical interventions often prove costly or produce unwanted adverse reactions, prompting investigation into alternative approaches.

Turmeric's primary bioactive component, curcumin, has demonstrated potential therapeutic properties for metabolic disorders, inflammation and weight management, though previous research yielded inconsistent outcomes.

Healthcare professionals advise patients to seek medical guidance before incorporating turmeric supplements into their treatment regimens, particularly those already receiving diabetes medications.

Potential interactions between supplements and prescribed pharmaceuticals require careful consideration.

LATEST DEVELOPMENTS

• Women with dementia found to have 20% lower levels of key nutrient than men, scientists warn
• 'I'm a doctor with 20 years of experience - ignoring these 5 cancer signs will cost you time'
• Covid may speed up blood vessel ageing by 5 years and boost heart disease and stroke risk

Commercial turmeric products typically contain between 500 and 1,000 milligrams of curcumin per serving, necessitating multiple doses to achieve therapeutic levels identified in the research.

Product quality varies significantly, with some formulations lacking adequate curcumin concentrations or bioavailability.

The meta-analysis authors acknowledged several limitations, including low evidence quality ratings for numerous trials and considerable variability between study methodologies.

Small sample sizes and reliance on self-reported data in certain trials potentially introduced bias, while the exclusion of pregnant women and combination therapies restricted the findings' applicability.